BioNTech SE (BNTX) Debt to Equity (2018 - 2021)

BioNTech SE has disclosed Debt to Equity across 4 years of filings, most recently posting $0.12 for Q4 2021.

• Debt to Equity for Q4 2021 came in at $0.12, down 34.28% year-over-year; the trailing twelve-month figure through Dec 2021 was $0.12 (down 34.28% YoY), and the FY2021 annual result was $0.12, down 34.28% from the prior year.
• Debt to Equity came in at $0.12 for Q4 2021 at BioNTech SE, down from $0.18 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.23 in Q4 2018 to a low of $0.12 in Q4 2021.
• The 4-year median for Debt to Equity is $0.18 (2020), against an average of $0.18.
• Across the five-year window, Debt to Equity increased 8.98% in 2020 and slumped 34.28% in 2021, its largest moves.
• BioNTech SE's Debt to Equity stood at $0.23 in 2018, then plunged by 31.37% to $0.16 in 2019, then rose by 8.98% to $0.18 in 2020, then plunged by 34.28% to $0.12 in 2021.
• The last three Debt to Equity figures came in at $0.12 (Q4 2021), $0.18 (Q4 2020), and $0.16 (Q4 2019), per Business Quant data.